HEALTH CATALYST, INC.
Income Statement
| Line Item | FY2018 | FY2017 |
|---|---|---|
| Revenue | $112.6M | $73.1M |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $38.6M | $28.5M |
| SG&A Expense | $22.7M | $14.7M |
| Operating Income | $-60.1M | $-45.5M |
| Operating Margin | -53.4% | -62.3% |
| Interest Expense | — | — |
| Pretax Income | — | — |
| Income Tax Expense | $-135.0K | $26.0K |
| Net Income | $-62.0M | $-47.0M |
| Net Margin | -55.1% | -64.4% |
| EPS (Basic) | $-11.88 | $-6.07 |
| EPS (Diluted) | $-11.88 | $-6.07 |
| Shares Outstanding (Basic) | — | — |
| Shares Outstanding (Diluted) | — | — |
| Dividends Per Share | — | — |